REST-driven upregulation of SFXN3 promotes AML progression via Wnt/β-catenin activation and confers decitabine resistance

One of the most diverse types of blood cancer is acute myeloid leukemia, or AML, and there remains an urgent need to identify novel molecular targets for its diagnosis and treatment. The present investigation identified Sideroflexin 3 (SFXN3) as a possible prognostic biomarker in AML by integrating...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Xiaoling Wang, Youcai Huang, Mingwei Sun, Shuyi Cai, Xiaoyu Hu, Yi Zheng, Shumin Fang, Sumei Li, Yanyang Tu, Huanwen Tang
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2026-04-01
Cyfres:	Translational Oncology
Pynciau:	SFXN3 REST Acute myeloid leukemia Wnt/β-catenin signaling Prognostic biomarker Decitabine sensitivity
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S1936523326000422
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!